Torii Pharmaceutical Revenue

In the year 2024, Torii Pharmaceutical had annual revenue of 60.43B JPY with 10.59% growth. Torii Pharmaceutical had revenue of 17.09B in the quarter ending December 31, 2024, with 10.23% growth.

Revenue

60.43B

Revenue Growth

+10.59%

P/S Ratio

2.08

Revenue / Employee

102.07M

Employees

592

Market Cap

125.91B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	60.43B	5.79B	10.59%
Dec 31, 2023	54.64B	5.74B	11.74%
Dec 31, 2022	48.90B	1.91B	4.06%
Dec 31, 2021	46.99B	5.29B	12.68%
Dec 31, 2020	41.70B	-1.30B	-3.02%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,170.61B
Takeda Pharmaceutical Company	4,579.02B
Daiichi Sankyo Company	1,795.99B
HOYA Corporation	838.60B
Terumo	1,011.15B
Otsuka Holdings	2,329.86B
Astellas Pharma	1,867.63B
Shionogi &	456.87B

Revenue Rankings